Peri-Implant and Peri-Prosthetic Fractures: Epidemiology, Morbidity, Mortality, Treatment and Outcome Analysis

NCT ID: NCT04663893

Last Updated: 2022-02-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-01-01

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study supports Spanish data collection and analysis on Periprosthetic and Peri-implant fractures of the upper and lower limb. Treatment and clinical management of this fractures are complex and goes along with complications. There will be more than 70 hospitals providing information. This study will provide evidence on which is the best treatment for every unique patient. This will help trauma surgeons and geriatricians to provide better treatments, to improve health care in our society, reducing mortality, morbidity, improving functional outcomes, and reducing costs, which in turn will be advances in trauma care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There is no clinical evidence on which are the best treatment options for Periprosthetic and Peri-implant fractures of the upper and lower limb. This is a multi-center collaborative study seeking to obtain a big number of patients. Data collection includes previous health status and quality of life, which is the clinical management and treatment, as well as the outcome after one month, six months and one year. The investigators will be able to define risk factors and clinical attitudes, which influence on the patient outcome. And therefore, be able to establish treatment protocols and give management recommendations based on the observed clinical evidence to improve healing indexes, morbidity and mortality, function, grade of autonomy and quality of live.

Main questions to be answered are: 1. which is the epidemiology of Periprosthetic and Peri-implant fractures and how are they treated in Spain, 2. Identify risk factors for complications and worse outcomes, 3. which is the morbidity and mortality, 4. influence of the fracture type and implants already placed on management and outcome, 5. influence of the treatment on patients' grade of independency, and 6. identified which are the risk factors for treatment failure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Periprosthetic Fracture of the Upper or Lower Limb Peri-implant Fracture of the Upper or Lower Limb Periprosthetic Fractures Peri-implant Fracture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient with the diagnose of Periprosthetic fracture of the shoulder, elbow, hip or knee. Or patients with the diagnose of Peri-implant fracture of the scapula, humerus, forearm, pelvis, femur, patella, tibia or fibula. Or patient presenting cut-out or cut-in after DHS or nail after a proximal humeral fracture.
* 18 years or older

Exclusion Criteria

* Spine PP or PI fracture
* PP or PI secondary to metastasis or tumoral fracture
* PP or PI intraoperative fracture
* PP or PI pathologic fracture
* PP ankle fracture
* PP or PI wrist or hand fracture
* Fixation failure without any new fracture line: except cut-out or cut-in after DHS or nail of a proximal humeral fracture.
* Pregnancy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital Mutua de Terrassa

OTHER

Sponsor Role collaborator

Althaia Xarxa Assistencial Universitària de Manresa

OTHER

Sponsor Role collaborator

Hospital Clinic of Barcelona

OTHER

Sponsor Role collaborator

Hospital Universitario 12 de Octubre

OTHER

Sponsor Role collaborator

Hospital Vall d'Hebron

OTHER

Sponsor Role collaborator

Hospital de Jove, Gijón, Spain

UNKNOWN

Sponsor Role collaborator

Hospital de Basurto

OTHER

Sponsor Role collaborator

Hospital Álvaro Cunqueiro

OTHER

Sponsor Role collaborator

Hospital Galdakao-Usansolo

OTHER_GOV

Sponsor Role collaborator

Hospital Universitario de Canarias

OTHER

Sponsor Role collaborator

Hospital Infanta Elena de Valdemoro, Madrid

UNKNOWN

Sponsor Role collaborator

Hospital Universitario Doctor Peset

OTHER

Sponsor Role collaborator

Hospital Royo Villanova - Ntra. Sra. de Gracia, Zaragoza

UNKNOWN

Sponsor Role collaborator

Hospital Universitario de Cabueñes, Asturias

UNKNOWN

Sponsor Role collaborator

Hospital Universitario Fundación Alcorcón, Madrid

UNKNOWN

Sponsor Role collaborator

Nuestra Señora de Sonsoles Hospital in Ávila

OTHER

Sponsor Role collaborator

Hospital Clínico Universitario San Carlos, Madrid

UNKNOWN

Sponsor Role collaborator

Complejo Hospitalario Universitario, A Coruña

UNKNOWN

Sponsor Role collaborator

Hospital Gregorio Marañón, Madrid

UNKNOWN

Sponsor Role collaborator

Hospital Universitario de Álava - Txagorritxu, Alava

UNKNOWN

Sponsor Role collaborator

Hospital Universitario General de Elche, Elche

UNKNOWN

Sponsor Role collaborator

Hospital Gral. Univ. Los Arcos del Mar Menor de Murcia

UNKNOWN

Sponsor Role collaborator

Hospital Vega Baja de Orihuela, Alicante

UNKNOWN

Sponsor Role collaborator

Hospital Gral. Univ. Morales Meseguer, Murcia

UNKNOWN

Sponsor Role collaborator

Hospital Can Misses, Ibiza

UNKNOWN

Sponsor Role collaborator

Hospital Son Llàtzer, Palma de Mallorca

UNKNOWN

Sponsor Role collaborator

Hospital Marqués de Valdecilla, Santander

UNKNOWN

Sponsor Role collaborator

Hospital Virgen de la Salud

OTHER

Sponsor Role collaborator

Hospital Puerta de Hierro, Madrid

UNKNOWN

Sponsor Role collaborator

Hospital General de Segovia

OTHER

Sponsor Role collaborator

Hospital Moisés Broggi de Sant Joan Despí, Barcelona

UNKNOWN

Sponsor Role collaborator

Hospital Universitari Sagrat Cor, Barcelona

UNKNOWN

Sponsor Role collaborator

Complejo Hospitalario Llerena-Zafra, Badajoz

UNKNOWN

Sponsor Role collaborator

Hospital Universitario Lucus Augusti

OTHER

Sponsor Role collaborator

Hospital Universitario La Paz

OTHER

Sponsor Role collaborator

Hospital Universitario Ramón y Cajal de Madrid

UNKNOWN

Sponsor Role collaborator

Hospital Universitario Pcpe. de Asturias de Alcalá de Henares, Madrid

UNKNOWN

Sponsor Role collaborator

Hospital General Universitario Reina Sofía, Murcia

UNKNOWN

Sponsor Role collaborator

Hospital General Obispo Polanco, Teruel

UNKNOWN

Sponsor Role collaborator

Hospital Universitario de Guadalajara

UNKNOWN

Sponsor Role collaborator

University Hospital of Girona Dr. Josep Trueta

NETWORK

Sponsor Role collaborator

Complejo Hospitalario Universitario de Albacete

OTHER

Sponsor Role collaborator

Hospital Sierrallana de Torrelavega, Cantabria

UNKNOWN

Sponsor Role collaborator

Complejo Hospitalario de Palencia

UNKNOWN

Sponsor Role collaborator

Hospital Universitario Fundación Jiménez Díaz, Madrid

UNKNOWN

Sponsor Role collaborator

Complexo Hospitalario Universitario de Pontevedra

UNKNOWN

Sponsor Role collaborator

Hospital Parc Taulí de Sabadell, Barcelona

UNKNOWN

Sponsor Role collaborator

Hospital Universitario Miguel Servet, Zaragoza

UNKNOWN

Sponsor Role collaborator

Hospital Universitari Arnau de Vilanova, Lleida

UNKNOWN

Sponsor Role collaborator

Hospital Universitario de León

UNKNOWN

Sponsor Role collaborator

Hospital Universitario de Burgos

OTHER

Sponsor Role collaborator

Hospital Santa Bárbara, Soria

UNKNOWN

Sponsor Role collaborator

Hospital San Pedro de Logroño

OTHER

Sponsor Role collaborator

Hospital Costa del Sol de Marbella, Málaga

UNKNOWN

Sponsor Role collaborator

Hospital Parc De Salut Mar, Barcelona

UNKNOWN

Sponsor Role collaborator

Hospital Italiano de Buenos Aires, Argentina

UNKNOWN

Sponsor Role collaborator

Complejo Hospitalario de Navarra

OTHER

Sponsor Role collaborator

Hospital Santos Reyes de Aranda de Duero, Burgos

UNKNOWN

Sponsor Role collaborator

Hospitales Universitarios Virgen del Rocío

OTHER

Sponsor Role collaborator

Hospital de la Santa creu i Sant Pau - Barcelona

OTHER

Sponsor Role collaborator

Hospital Universitario Dr. Negrín, Gran Canaria

UNKNOWN

Sponsor Role collaborator

Hospital Universitario Infanta Leonor, Madrid

UNKNOWN

Sponsor Role collaborator

Hospital Comarcal Alto Guadalquivir de Andújar, Jaén

UNKNOWN

Sponsor Role collaborator

Hospital Universitario de Donostia, Guipúzcoa

UNKNOWN

Sponsor Role collaborator

Hospital Carmen y Severo Ochoa de Cangas de Narcea, Asturias

UNKNOWN

Sponsor Role collaborator

Hospital Reina Sofía de Tudela, Navarra

UNKNOWN

Sponsor Role collaborator

Hospital Universitario San Agustín de Avilés, Asturias

UNKNOWN

Sponsor Role collaborator

Hospital Universitario Virgen de la Macarena, Sevilla

UNKNOWN

Sponsor Role collaborator

Hospital Universitario El Escorial, Madrid

UNKNOWN

Sponsor Role collaborator

Hospital Clínico Universitario de Valladolid

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Héctor J Aguado

MD PhD Associate Professor Trauma/Orthogeriatric unit

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Héctor J Aguado, MD PhD

Role: STUDY_DIRECTOR

Hospital Clínico Universitario Valladolid

Pablo Castillón, MD PhD

Role: STUDY_DIRECTOR

Mútua Universitaria de Terrassa

Josep M Muñoz Vives, MD PhD

Role: PRINCIPAL_INVESTIGATOR

Althaia Xarxa Assistencial Universitària de Manresa

Cristina Ojeda-Thies, MD PhD

Role: PRINCIPAL_INVESTIGATOR

Hospital 12 de Octubre, Madrid

Pilar Camacho, MD PhD

Role: PRINCIPAL_INVESTIGATOR

Hospital Clinic of Barcelona

Jordi Teixidor, MD

Role: PRINCIPAL_INVESTIGATOR

Hospital Universitario Vall d´Hebrón

Pablo García-Portablella, MD

Role: PRINCIPAL_INVESTIGATOR

Hospital de Jove, Gijón

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mutua Universitaria de Tarrasa

Barcelona, , Spain

Site Status RECRUITING

Althaia, Xarxa Assistencial Universitària de Manresa

Barcelona, , Spain

Site Status RECRUITING

Hospital Clinic

Barcelona, , Spain

Site Status RECRUITING

Hospital Universitario Vall d´Hebrón

Barcelona, , Spain

Site Status RECRUITING

Hospital de Jove

Gijón, , Spain

Site Status RECRUITING

Hospital Universitario 12 de Octubre

Madrid, , Spain

Site Status RECRUITING

Hospital Clínico Universitario de Valladolid

Valladolid, , Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Adela Pereda-Manso

Role: CONTACT

+34983420000 ext. 86366

Montsant Jornet

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Judith López Catena

Role: primary

Josep M Muñoz Vives, MD PhD

Role: primary

Montsant Jornet

Role: primary

Jordi Teixidor, MD

Role: primary

Pablo Garcia-Portabella, MD

Role: primary

Cristina Ojeda-Thies, MD PhD

Role: primary

Adela Pereda Manso

Role: primary

+34983420000 ext. 86366

References

Explore related publications, articles, or registry entries linked to this study.

PIPPAS Study Group. Optimizing periprosthetic fracture management and in-hospital outcome: insights from the PIPPAS multicentric study of 1387 cases in Spain. J Orthop Traumatol. 2024 Mar 7;25(1):13. doi: 10.1186/s10195-024-00746-6.

Reference Type DERIVED
PMID: 38451303 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PI 20-2041

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.